Clinical Trial Update: Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

View source ↗

Summary

A terminated clinical trial evaluated whether Sorafenib or Regorafenib affects P63 expression and keratinocyte differentiation in human skin among patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma
• Hepatocellular Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Regorafenib (regorafenib)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Renal Cell Carcinoma, Hepatocellular Carcinoma | Status: TERMINATED